SCHEMBL21881890

SCHEMBL21881890

CP(C)(=O)c1cccc(-c2ccc(-c3ccc(-c4nc(-c5ccccc5)nc5ccccc45)cc3)c3ccccc23)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.51
KMT2A Q03164 4/20 0.51
ATM Q13315 1/20 0.51
WHR1 P49842 1/20 0.42
PDK1 Q15118 2/20 0.40
NUDT1 P36639 3/20 0.38
ADORA2A P29274 2/20 0.38
ABCG2 Q9UNQ0 6/20 0.37
ADORA3 P0DMS8 1/20 0.37
MAPT P10636 3/20 0.37
ABCB1 P08183 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
PDE5A O76074 1/20 0.36
MAPK1 P28482 2/20 0.36
USP2 O75604 1/20 0.36
CYP1A2 P05177 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21881887 0.89 L3MBTL1 (0.39) MEN1KMT2AATMABCG2ADORA3
SCHEMBL30865645 0.89 L3MBTL1 (0.39) MEN1KMT2AATMABCG2ADORA3
SCHEMBL21881921 0.88 MEN1 (0.51) MEN1KMT2AATMWHR1PDK1
SCHEMBL21881759 0.85 HDAC8 (0.38) MEN1KMT2AATMWHR1PDK1
SCHEMBL25787296 0.83 L3MBTL1 (0.39) MEN1KMT2AWHR1ABCG2ADORA3
SCHEMBL22020412 0.82 HDAC8 (0.38) SMN1; SMN2KDM4EMAPK1HSD17B10
SCHEMBL21881758 0.82 ALDH1A1 (0.44) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL27398053 0.80 MEN1 (0.43) MEN1KMT2AADORA2AADORA3MAPT
SCHEMBL27242384 0.80 CYP1A1 (0.36) MEN1KMT2AATMWHR1MAPT
SCHEMBL22652722 0.79 MEN1 (0.69) MEN1KMT2AATMWHR1NUDT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device NOVALED GMBH (DE) 2023-10-24 US disclosed
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device NOVALED GMBH (DE) 2023-10-24 US disclosed
US-20200095269-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device NOVALED GMBH (DE) 2020-03-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200095269-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device C1S, C1R, CCNA1 MEN1 762/4885KMT2A 3297/4885ATM 2974/4885
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device C1S, C1R, CCNA1 MEN1 762/4885KMT2A 3297/4885ATM 2974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.